ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,381.60
-0.57%
S&P ASX All Technology
3,886.20
-0.02%
Brent Oil
78.075
-0.33%
US Dollar vs AUD
1.59424
0.01%
Bitcoin
102,315.88
-1.27%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Envista Holdings Corporation (NVST)

  7. Envista Holdings Corporation (NVST) News

Envista Holdings Corporation

Envista Holdings Corporation (NVST)

NYSE
21.05
0.50
(2.43%)
Closed 23 January 8:00AM
Delayed by 15 minutes
21.05
0.00
(0.00%)
After Hours: 9:00AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

NVST News

Official News Only

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 February 2024
NVST (2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 February 2024
NVST (2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 February 2024
NVST (2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 February 2024
NVST (2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 February 2024
NVST (2.43%)

Form 8-K - Current report
Edgar (US Regulatory)
27 February 2024
NVST (2.43%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
22 February 2024
NVST (2.43%)

Form 8-K - Current report
Edgar (US Regulatory)
08 February 2024
NVST (2.43%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 February 2024
NVST (2.43%)

Discussion

View Full Feed
weedtrader420 weedtrader420 3 minutes ago
BITCOIN XRP AIMAW Aqualung💦Cross eyed Mary $120,000 TARGET ✊😮‍💨☝️
BTCUSD
Saving Grace Saving Grace 5 minutes ago
Yes, when NDA's are removed, it's boom time. Everyone at the plant is excited and ready.

https://businessjournaldaily.com/wp-content/uploads/2024/10/Foxconn-Model-C-EV.jpg

https://i.vimeocdn.com/video/1780032285-1eadf9821975b71cc554aa3a7d443a4b59265d9b3a16081b2573d7c443
NRDE
ThoroughBread ThoroughBread 7 minutes ago
SFIO .0028 sleeper.
SFIO
glens0 glens0 8 minutes ago
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 10 minutes ago
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 10 minutes ago
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 11 minutes ago
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 12 minutes ago
KPIFF
wadegarret wadegarret 12 minutes ago
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 12 minutes ago
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 13 minutes ago
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 15 minutes ago
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 15 minutes ago
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 15 minutes ago
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 16 minutes ago
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 17 minutes ago
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 18 minutes ago
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 18 minutes ago
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 19 minutes ago
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 20 minutes ago
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 20 minutes ago
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 23 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 23 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL

Your Recent History

NYSE
NVST
Envista
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads